做多
NOVN - New VP... Trend Continues
Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.
SHORT INTEREST
837.72K 08/15/19
P/E Current
-4.17
P/E Ratio (with extraordinary items)
-2.14
Average Recommendation: OVERWEIGHT
Average Target Price: 6.00
SHORT INTEREST
837.72K 08/15/19
P/E Current
-4.17
P/E Ratio (with extraordinary items)
-2.14
Average Recommendation: OVERWEIGHT
Average Target Price: 6.00
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。